The EU introduction of mitotane [Lysodren; HRA Pharma] 500mg tablets is to go ahead once pricing and reimbursement issues have been settled

Source: Inpharma, Volume 1, Number 1442, 2004-06-19 , pp. 18-18(1)

Publisher: Adis International

Keywords: Mitotane, therapeutic use; Product-approvals

Document Type: Short communication

Publication date: 2004-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers